Veracyte, Inc.VCYT
Price as of · delayed, not real-time
Specializing in genomic diagnostics, this company provides precision medicine solutions for cancer and other diseases through its proprietary testing platforms. Veracyte has established itself as a key player in molecular diagnostics, with investors monitoring its growth in the expanding market for non-invasive diagnostic tools. The firm's tests are used by clinicians to guide treatment decisions, reducing unnecessary procedures and healthcare costs.
Congressional Interest in Veracyte, Inc. (VCYT)
3 members of Congress have disclosed 15 trades in Veracyte, Inc. (VCYT), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 7 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading VCYT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K-$15K |
| 2026-02-18 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-11-12 | Gilbert Cisneros | sell | $1K-$15K |
| 2025-06-16 | Gilbert Cisneros | buy | $1K-$15K |
| 2023-10-16 | Josh Gottheimer | buy | $1K-$15K |
| 2023-09-15 | Josh Gottheimer | sell | $1K-$15K |
| 2023-04-10 | Daniel Goldman | sell | $1K-$15K |
| 2020-12-23 | Gilbert Cisneros | sell | $1K-$15K |
| 2020-12-10 | Gilbert Cisneros | sell | $1K-$15K |
| 2020-12-08 | Josh Gottheimer | sell | $1K-$15K |
| 2020-10-29 | Gilbert Cisneros | sell | $1K-$15K |
| 2020-01-17 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-12-24 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-12-12 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-12-06 | Josh Gottheimer | buy | $1K-$15K |